Results 181 to 190 of about 211,755 (262)

Differentiation Syndrome and Sweet Syndrome‐Like Overlap Following Venetoclax–Azacytidine and G‐CSF Therapy

JEADV Clinical Practice, EarlyView.
ABSTRACT Differentiation syndrome (DS) and Sweet syndrome (SS) are inflammatory complications mediated by cytokine dysregulation, classically associated with therapies that promote myeloid differentiation or cytokine release. While DS has been primarily linked to all‐trans retinoic acid (ATRA) and IDH inhibitors, recent evidence suggests that ...
Katerina Grafanaki, Maria Gerbesi, Zoe Apalla, Dimitrios Tsokanas, Efstathia Pasmatzi, Alexandros Spyridonidis, Maria Liga   +6 more
wiley   +1 more source

A mitochondrial-based prognostic score for risk stratification in acute myeloid leukemia. [PDF]

Blood Res
Santos IC, Silva-Xavier VJ, Moreira-Aguiar A, Reis-Silva MT, Silva LP, França-Neto PL, Bezerra MA, Machado-Neto JA, Pereira-Martins DA, Lucena-Araujo AR, Coelho-Silva JL.   +10 more
europepmc   +1 more source

Nail Toxicities Associated With Anticancer Therapies in Children

JEADV Clinical Practice, EarlyView.
ABSTRACT Nail toxicities are a frequent yet often underrecognized component of dermatologic adverse events in children receiving anticancer therapies. Both conventional cytotoxic chemotherapy and newer targeted agents can affect the nail matrix, nail bed and periungual tissues, producing a broad spectrum of clinical manifestations that range from ...
Luca Rapparini, Michela Starace
wiley   +1 more source

Leukemia cutis as the first manifestation of acute myeloid leukemia. [PDF]

J Dtsch Dermatol Ges
Winkler F, Brand R, Mehic D, Tuchmann F, Valero T, Strobl J.   +5 more
europepmc   +1 more source

Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing N6‐Methyladenosine Methylation of Myc

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Ibrutinib resistance remains a major obstacle in the treatment of diffuse large B‐cell lymphoma (DLBCL). Fat mass and obesity‐associated protein (FTO) has been implicated in drug resistance through its regulation of N6‐methyladenosine (m6A) modifications; however, whether FTO mediates ibrutinib resistance in DLBCL remains unclear.
Ting‐Ting Lu, Jin‐Hao Chen, Yan‐Fang Wang, Xiao Wu, Hui‐Yun Ni, Qiu‐Rong Zhang   +5 more
wiley   +1 more source

Oral Leukemia Cutis and Facial Sweet's Syndrome Associated with Acute Myeloid Leukemia.

Indian J Dermatol
Manzone SZ, Anderlini C, Salduna D, Calafat P, Kurpis M, Valente E.   +5 more
europepmc   +1 more source

Apoptosis-related gene model predicts the prognosis in patients with acute myeloid leukemia. [PDF]

Blood Sci
Pei X, Liu W, Li Y, Wei H, Wang M, Wang J.   +5 more
europepmc   +1 more source

Oncogenic KRAS Rewires Stress Granule Dynamics: Mechanisms and Therapeutic Opportunities

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Stress granules (SGs) are dynamic, membrane‐less structures that form in response to various cellular stresses, including metabolic, oxidative, and therapeutic challenges. They function as adaptive hubs and reorganize protein synthesis and signaling networks to help cells survive under stress. In cancer, these condensates are often hijacked to
Msimisi Ndzinisa, Birhanetensay Masresha Altaye, Yuh‐Pyng Sher   +2 more
wiley   +1 more source

Metabolic Subtypes Predict Treatment Response in Acute Myeloid Leukemia: A Pilot Study. [PDF]

Blood Lymphat Cancer
Yan C, Huang Y, Cai Q, Li X, Yang Q, Feng G, Yang H, Chen Y, Hu J.   +8 more
europepmc   +1 more source